A Platform Supporting Oligonucleotide and mRNA Drug Developers in Identifying Best-Matched Global CDMO and CRDMO Partners

Who We Are

Oligolink is an independent platform that connects oligonucleotide and mRNA drug developers with trusted, quality-assured CDMO and CRDMO partners. We help companies find the right partners and work together efficiently across the drug development process, including raw material supply, research, and manufacturing.

By understanding both development needs and service capabilities, Oligolink supports companies in overcoming key challenges in oligonucleotide and mRNA development, such as process development, scale-up, drug delivery, and reliable access to key raw materials. We focus on matching the right technologies, expertise, and resources to each project while remaining transparent and independent.

Oligolink works closely with a network of qualified CDMO and CRDMO partners, including multiple providers in China and other regions. We have a strong understanding of the strengths and specialties of CDMO and CRDMO providers in China, as well as their raw material capabilities, which allows us to select the most suitable partners for each project.

With the ultimate goal of accelerating drug development and helping patients access innovative therapies as early as possible.